A D Kirk. Show Affiliations »
Abstract
Mesh: See more » AlemtuzumabAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/therapeutic useGraft Rejection/prevention & controlHumansKidney TransplantationLymphocyte Depletion
Substances: See more » Antibodies, Monoclonal, HumanizedAlemtuzumab
Year: 2012 PMID: 23167297 DOI: 10.1111/j.1600-6143.2012.04324.x
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086